Interestingly, diminished insulin-stimulated AKT signaling has been documented in the total lymphocytes of obese individuals (Viardot et al., 2007), and reduced expression of insulin receptor and downstream signaling molecules have also been reported in patients with type 2 diabetes (Stentz and Kitabchi, 2007). This evidence concerns the gene INS and type 2 diabetes mellitus.